- Home
- SUPN vs CCU Comparison
SUPN vs CCU Comparison
Compare SUPN & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUPN | CCU |
|---|---|---|
| Founded | 2005 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2010 | 2001 |
Fundamental Metrics
Financial Performance| Metric | SUPN | CCU |
|---|---|---|
| Price | $54.18 | $13.32 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $61.60 | $12.00 |
| AVG Volume (30 Days) | ★ 781.0K | 177.4K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | ★ 6500.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $392,755,000.00 | N/A |
| Revenue This Year | $8.18 | $10.61 |
| Revenue Next Year | $22.15 | $5.28 |
| P/E Ratio | ★ N/A | $18.35 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.16 | $11.35 |
| 52 Week High | $59.68 | $15.75 |
Technical Indicators
Market Signals| Indicator | SUPN | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 35.91 |
| Support Level | $47.95 | $12.48 |
| Resistance Level | $57.65 | $13.49 |
| Average True Range (ATR) | 2.13 | 0.40 |
| MACD | 0.49 | -0.16 |
| Stochastic Oscillator | 46.18 | 4.82 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.